Item | Notes |
---|
Quorum evaluation (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business) | Currently we have 19 named members, so 2/3 = 12 (excluding chair and government members). |
Open Meeting | 12:0? PM ET |
Collaborative Community Panel Presentation | Request to participate in Panel on December 17, 2024 3:50 - 4:20 PM ET - these would be the questions; Riki would attend, Andrea would join if she can. Question 1: Please briefly refresh the audience regarding the vision, objectives, key participants, and scope of activities in your Collaborative Community, including highlights of recent and ongoing activities and upcoming milestones or events. [3-5 minutes] Question 2: What have been the biggest challenges or barriers to achieving standardized methodology and data structures (interoperability) across variety of data-generating devices, lab tests, and organizations? Question 3 [back-up, time-permitting]: How has your CC sought to balance the competing needs for both innovation & standardization?
|
Conferences | ASCLS got submitted - waiting for response ADLM got submitted - waiting for response |
Review Working Groups progress | Setting milestones for deliverables should be NEXT for WGs: they will be captured here: SHIELD WG Deliverables and Milestone Grid |
LOINC question | Got question if LOINC would support IFCC methods (as part of harmonization of tests) or should this be covered by the yet to created harmonization indicator? Example: Hemoglobin A1C |
Administrative things | Review SC Composition, terms and requirements for re-voting: Representative first 3 year terms expire 12/20/2025 Chair and Vice Chair 2 year terms expire 3/14/2025 90 days would be 12/14/2024 for call for nominations for Chair and Vice-Chair, so folks, start thinking about who might want to take the reins email Andrea and Riki with any nominations
Steering Committee attendance review: consider Consider changing timeslot - what are some options?
|
Roadmap section updates in response to ONC comments on the SHIELD roadmap | The roadmap mission section describes a broad vision of lab interoperability. However, the roadmap proposed solution is limited to the FDA use cases around In-vitro diagnostics (IVD) data, specifically populating the IVD data hub. ONC suggests clearly describing the roadmap scope so the proposed solutions can be discussed within that context.
Updated language draft:Roadmap update: ONC Feedback maybe add one more sentence or add a reference to the key consideration number for the IVD Datahub (Consideration 4) into these sentences. (change approved in principle.) Discussion: The roadmap identifies training and education needs around using LOINC as a barrier to interoperability. ONC suggests clarifying how the roadmap addresses this barrier. ONC recognizes that terminologies require training and education, and replacing LOINC with another standard will not address the barrier.
Update from Standards and Vocab WG about re-write of this section - from their March 18th call (notes here, recording here) Concepts around Healthcare IT (HIT) standards needs to be conveyed earlier in training for healthcare providers as use and application of standards in vended applications is the major gap. Decision making to use Health IT standards are less likely left up to IT analysts as they mainly follow the requirements and then they generally use vendor supplied implementation guidance. However, a vendor may not support functionality for standards or only partially support. Regulatory requirements (such as CLIA) may pose a hurdle to implementation of data standards. Implementation guidance is often not well read. Training resources may not be well publicized or readily available. Perhaps conformance testing tools need to be made more widely available? What might be helpful is to look at standards implementation from a data lifecycle standpoint across all users (end to end across ecosystem), rather than just training on a single standard for a single use case. Last paragraph on page 4 of the road map final version could be augmented with these points.
Discussion: There are several solutions proposed, including repositories and tools, which need to be further evaluated before ONC could fully support the roadmap. ONC suggests the roadmap be updated to include details around feasibility, scalability and how the proposed changes can be integrated into the current laboratory ecosystem (e.g., regulation and industry).
Identify components that could improve the ecosystem infrastructure, and then highlight the places where these components can be advanced / sustained or made easier to implement. Would SHIELD be willing to consider to provide an example implementation - create the structures and bound terminologies to showcase how each element would be properly represented be working. For each of the Consideration sections we could certainly add a section on feasibility / requirements (e.g. continued funding for LIDR, better describing the intended use of ANY data element added, overall goal of LIDR, clearly delineate what is commonly used and is minimum, provide best practice and alternatives (non-preferred) - example would be metadata around the value sets in VSAC (curation / usage etc) to be able to ascertain quality) and highlight that other mechanisms are needed to achieve for adoption. |
ONC Annual Meeting December 4-5, 2024 Omni Shoreham in Washington, DC | https://www.astpannualmeeting.com/Agenda This is in-person only, registration is open now - last year it filed up no plans so far to have slides / recording available December 5th 2:15 – 3:15 pm is Enhancing Laboratory Interoperability: Insights and a Path Forward - Sara can give update afterwards |
Antimicrobial result reporting | Placeholder to get back to later Related work at HL7 Europe: View file |
---|
name | EU coded value sets.xlsx |
---|
|
|
Next calls | All SHIELD Calls November 26th December 17th
General Updates: 2024 - WG Chairs please make sure we have material for updates (at least notes we can link to) Special Topic: Steering Committee: |
Adjourned | 12: PM ET |